As a global leader in AI-powered imaging for oncology clinical trials, Median’s iCRO business is dedicated to providing best-in-class imaging services to our life sciences partners. But we don’t stop there. We are leading the way when it comes to AI-powered imaging, leveraging the latest in AI/ML technology to provide actionable insights for sponsors around the world.  
 
As a part of this commitment, we have brought together industry visionaries, Fredrik Brag, our CEO and Founder, and Dr Yan Liu, our Chief Medical Officer, for a podcast to discuss:
 
• AI-powered imaging and its advantages for sponsors and patients, using lung cancer as the framework for discussion.
• AI’s importance in providing big data insights into patient selection and finding early stage patients for oncology clinical trials.
• And much more about AI’s potential to impact how we leverage imaging data for the advancement of cancer research 
 
Want to learn more about the Competitive Advantages of AI-powered Clinical Trial Imaging to Advance Human Health? Listen to the podcast now! https://pages.pharmaintelligence.informa.com/median-podcast

See all Member News